Orally delivered baclofen to control spastic hypertonia in acquired brain injury.
about
A pharmacokinetic-pharmacodynamic model for intrathecal baclofen in patients with severe spasticity.Motor impairment rehabilitation post acquired brain injury.Baclofen in the Therapeutic of Sequele of Traumatic Brain Injury: Spasticity.Intrathecal baclofen therapy for spastic hypertonia in chronic traumatic brain injury.Care management of spasticity with botulinum toxin-A in patients with severe acquired brain injury: a 1-year follow-up prospective study.
P2860
Orally delivered baclofen to control spastic hypertonia in acquired brain injury.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Orally delivered baclofen to control spastic hypertonia in acquired brain injury.
@ast
Orally delivered baclofen to control spastic hypertonia in acquired brain injury.
@en
type
label
Orally delivered baclofen to control spastic hypertonia in acquired brain injury.
@ast
Orally delivered baclofen to control spastic hypertonia in acquired brain injury.
@en
prefLabel
Orally delivered baclofen to control spastic hypertonia in acquired brain injury.
@ast
Orally delivered baclofen to control spastic hypertonia in acquired brain injury.
@en
P2093
P1476
Orally delivered baclofen to control spastic hypertonia in acquired brain injury.
@en
P2093
Jay M Meythaler
Linda K Davis
Robert C Brunner
Sharon Guin-Renfroe
Warren Clayton
P304
P356
10.1097/00001199-200403000-00003
P577
2004-03-01T00:00:00Z